JPH01180451A - Adsorptive body for affinity separation - Google Patents
Adsorptive body for affinity separationInfo
- Publication number
- JPH01180451A JPH01180451A JP63003567A JP356788A JPH01180451A JP H01180451 A JPH01180451 A JP H01180451A JP 63003567 A JP63003567 A JP 63003567A JP 356788 A JP356788 A JP 356788A JP H01180451 A JPH01180451 A JP H01180451A
- Authority
- JP
- Japan
- Prior art keywords
- ligand
- carrier
- enzyme
- acid
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000926 separation method Methods 0.000 title claims description 22
- 230000000274 adsorptive effect Effects 0.000 title abstract 2
- 239000003446 ligand Substances 0.000 claims abstract description 29
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims abstract description 9
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229960004889 salicylic acid Drugs 0.000 claims abstract description 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract description 4
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims abstract description 4
- 239000003463 adsorbent Substances 0.000 claims description 25
- 108091005804 Peptidases Proteins 0.000 claims description 10
- 239000004365 Protease Substances 0.000 claims description 9
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 6
- 238000000034 method Methods 0.000 abstract description 16
- 238000000746 purification Methods 0.000 abstract description 16
- 238000010828 elution Methods 0.000 abstract description 13
- 125000000524 functional group Chemical group 0.000 abstract description 9
- 125000003277 amino group Chemical group 0.000 abstract description 6
- 238000006243 chemical reaction Methods 0.000 abstract description 5
- CYMRPDYINXWJFU-UHFFFAOYSA-N 2-carbamoylbenzoic acid Chemical compound NC(=O)C1=CC=CC=C1C(O)=O CYMRPDYINXWJFU-UHFFFAOYSA-N 0.000 abstract description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract description 3
- 230000003100 immobilizing effect Effects 0.000 abstract description 3
- 238000006149 azo coupling reaction Methods 0.000 abstract description 2
- 238000009833 condensation Methods 0.000 abstract description 2
- 230000005494 condensation Effects 0.000 abstract description 2
- 230000018044 dehydration Effects 0.000 abstract description 2
- 238000006297 dehydration reaction Methods 0.000 abstract description 2
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 abstract description 2
- 230000002194 synthesizing effect Effects 0.000 abstract 3
- 150000001732 carboxylic acid derivatives Chemical class 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 description 33
- 108090000790 Enzymes Proteins 0.000 description 33
- 229940088598 enzyme Drugs 0.000 description 32
- 239000011347 resin Substances 0.000 description 22
- 229920005989 resin Polymers 0.000 description 22
- 238000001179 sorption measurement Methods 0.000 description 11
- 239000007864 aqueous solution Substances 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- DQMAUXIQILXETR-UHFFFAOYSA-N 5-[(4-aminophenyl)diazenyl]-2-hydroxybenzoic acid Chemical compound C1=CC(N)=CC=C1N=NC1=CC=C(O)C(C(O)=O)=C1 DQMAUXIQILXETR-UHFFFAOYSA-N 0.000 description 7
- 238000011084 recovery Methods 0.000 description 7
- 150000003839 salts Chemical class 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 5
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 5
- 238000001042 affinity chromatography Methods 0.000 description 5
- 239000000969 carrier Substances 0.000 description 5
- 239000003480 eluent Substances 0.000 description 5
- 239000008363 phosphate buffer Substances 0.000 description 5
- 229910052938 sodium sulfate Inorganic materials 0.000 description 5
- 235000011152 sodium sulphate Nutrition 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 102000035195 Peptidases Human genes 0.000 description 4
- 229920002684 Sepharose Polymers 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 108010056079 Subtilisins Proteins 0.000 description 4
- 102000005158 Subtilisins Human genes 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- LVKZSFMYNWRPJX-UHFFFAOYSA-N phenylarsonic acid Chemical compound O[As](O)(=O)C1=CC=CC=C1 LVKZSFMYNWRPJX-UHFFFAOYSA-N 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000011324 bead Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- 229920005654 Sephadex Polymers 0.000 description 2
- 239000012507 Sephadex™ Substances 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- CBCKQZAAMUWICA-UHFFFAOYSA-N 1,4-phenylenediamine Chemical compound NC1=CC=C(N)C=C1 CBCKQZAAMUWICA-UHFFFAOYSA-N 0.000 description 1
- WZFUQSJFWNHZHM-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 WZFUQSJFWNHZHM-UHFFFAOYSA-N 0.000 description 1
- FZZMTSNZRBFGGU-UHFFFAOYSA-N 2-chloro-7-fluoroquinazolin-4-amine Chemical compound FC1=CC=C2C(N)=NC(Cl)=NC2=C1 FZZMTSNZRBFGGU-UHFFFAOYSA-N 0.000 description 1
- OXSANYRLJHSQEP-UHFFFAOYSA-N 4-aminophthalic acid Chemical compound NC1=CC=C(C(O)=O)C(C(O)=O)=C1 OXSANYRLJHSQEP-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 108091005658 Basic proteases Proteins 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241001319148 Pharmacis Species 0.000 description 1
- LGRFSURHDFAFJT-UHFFFAOYSA-N Phthalic anhydride Natural products C1=CC=C2C(=O)OC(=O)C2=C1 LGRFSURHDFAFJT-UHFFFAOYSA-N 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 108010027597 alpha-chymotrypsin Proteins 0.000 description 1
- 150000003862 amino acid derivatives Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- BUSBFZWLPXDYIC-UHFFFAOYSA-N arsonic acid Chemical compound O[AsH](O)=O BUSBFZWLPXDYIC-UHFFFAOYSA-N 0.000 description 1
- JHIWVOJDXOSYLW-UHFFFAOYSA-N butyl 2,2-difluorocyclopropane-1-carboxylate Chemical compound CCCCOC(=O)C1CC1(F)F JHIWVOJDXOSYLW-UHFFFAOYSA-N 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- YVWBQGFBSVLPIK-UHFFFAOYSA-N cyclohex-2-ene-1-carboxylic acid Chemical compound OC(=O)C1CCCC=C1 YVWBQGFBSVLPIK-UHFFFAOYSA-N 0.000 description 1
- APGFPQCBDNWQSB-UHFFFAOYSA-N cyclohexa-1,3-diene-1-carboxylic acid Chemical compound OC(=O)C1=CC=CCC1 APGFPQCBDNWQSB-UHFFFAOYSA-N 0.000 description 1
- 239000003398 denaturant Substances 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 238000011067 equilibration Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229960000789 guanidine hydrochloride Drugs 0.000 description 1
- PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 108010003855 mesentericopeptidase Proteins 0.000 description 1
- 108010020132 microbial serine proteinases Proteins 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000005373 porous glass Substances 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- GJAWHXHKYYXBSV-UHFFFAOYSA-N quinolinic acid Chemical compound OC(=O)C1=CC=CN=C1C(O)=O GJAWHXHKYYXBSV-UHFFFAOYSA-N 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Landscapes
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Description
【発明の詳細な説明】
(1)産業上の利用分野
本発明は、蛋白質分解酵素(fロチアーゼ)の分離、精
製等に有用なアフィニティー分離用吸着体に関する。DETAILED DESCRIPTION OF THE INVENTION (1) Industrial Application Field The present invention relates to an adsorbent for affinity separation useful for separation, purification, etc. of proteolytic enzymes (f-lothiase).
(2)従来の技術及び問題点
近年、蛋白質の精製法の一つとして、アフィニティー分
離を利用する方法が一般的に広く行なわれており、その
為のアフィニティークロマトグラフィー用吸着体が各種
開発され、実用化されている。(2) Conventional techniques and problems In recent years, methods using affinity separation have been widely used as one of the protein purification methods, and various adsorbents for affinity chromatography have been developed for this purpose. It has been put into practical use.
しかし、これらアフィニティー分離法は大部分のものが
ある程度精製されたものの精製、つまり、全精製プロセ
スの最終ステップに用いられることが多く、この場合、
精製プロセス全体としては多くのステツブからなるため
複雑で目的物の回収率も低くなる。今までに、比較的単
純なプロセスで、且、工業的大量精製に適したアフィニ
ティー分離法はなかった。However, most of these affinity separation methods are used to purify products that have been purified to some extent, that is, in the final step of the overall purification process;
The entire purification process consists of many steps, making it complex and resulting in a low recovery rate of the target product. Until now, there has been no affinity separation method that is a relatively simple process and is suitable for industrial large-scale purification.
また、酵素を精製する分野、特にアルカリグロチアーゼ
の精製分野では、アミノ酸、アミノ酸誘導体、蛋白性阻
害剤、ペグチド性阻害剤等の種々のリガンドが開発され
ているが、実用的溶離特性を得るための溶離条件は酵素
にとって苛酷なものが多く1例えば、アルコール、アセ
トン等の有機溶媒系、高または低−系、尿素、塩酸グア
ニジン等の蛋白質変性剤系等を用いたものがほとんどで
ある。これらの方法では溶離液中でプロテアーゼは不安
定となるため、溶離の時間や温度が制限され、工業的大
規模な精製には向いていない。また、プロテアーゼを安
定な条件下に移す必要があるため、有機溶媒回収系、P
H中和槽、変性剤の除外系等が必要となり、プロセスが
複雑になる欠点を有する。In addition, in the field of enzyme purification, particularly in the field of alkaline glothiase purification, various ligands such as amino acids, amino acid derivatives, proteinaceous inhibitors, and pegylated inhibitors have been developed, but it is difficult to obtain practical elution characteristics. The elution conditions for this are often harsh for enzymes; for example, most elution conditions use organic solvents such as alcohol and acetone, high or low solvent systems, and protein denaturant systems such as urea and guanidine hydrochloride. In these methods, the protease becomes unstable in the eluent, which limits the elution time and temperature, making it unsuitable for large-scale industrial purification. In addition, since it is necessary to transfer the protease to stable conditions, an organic solvent recovery system, P
This method requires a H neutralization tank, a denaturing agent exclusion system, etc., and has the disadvantage of complicating the process.
一方、温和な条件でアルカリプロテアーゼヲ溶離可能な
ものとしては、今までにフェニルアルソン酸系及びフェ
ニルホウ酸系のリガンドが知られていたが、フェニルア
ルソン酸系のリガンドはヒ素を含有しており有毒である
ため、吸着体調製時に大量に扱うには危険性を伴い、ま
た、プロテアーゼの精製時に於てもリガンドの脱離を完
全に防ぐことも難しい。したがって、このリガンドを扱
う方法は除害系が必要となり、プロセスが複雑になる等
の欠点を有する。また、フェニルホウ酸系のリガンドで
は吸着のプロテアーゼに対する選択が低く、プロテアー
ゼの吸着と競合するような物質を充分線いておく必要が
あり、また、溶離時では、このリガンドが吸着したプロ
テアーゼが溶離しにくいため、溶離液量を多く必要とし
、溶離時間も長くなる等の欠点を有する。On the other hand, phenylarsonic acid-based and phenylboronic acid-based ligands have been known to be able to elute alkaline protease under mild conditions, but phenylarsonic acid-based ligands contain arsenic and are toxic. Therefore, it is dangerous to handle large quantities when preparing an adsorbent, and it is also difficult to completely prevent desorption of the ligand during protease purification. Therefore, this method of handling the ligand requires a detoxification system and has drawbacks such as complicating the process. In addition, phenylboric acid-based ligands have low selectivity for adsorption of proteases, so it is necessary to sufficiently exclude substances that compete with protease adsorption, and during elution, proteases adsorbed with this ligand are difficult to elute. Therefore, it has drawbacks such as requiring a large amount of eluent and requiring a long elution time.
本発明の目的は、前記従来のアフィニティー分離用吸着
体の欠点を克服して、プロテアーゼ、例えば、アルカリ
グロチアーゼを中性〜弱塩基性の水溶液で溶離可能で、
大量精製に十分対応できる吸着溶離特性を持つ安全なア
フィニティー分離用吸着体およびそれを用いるプロテア
ーゼの精製法を提供することKある。An object of the present invention is to overcome the drawbacks of the conventional adsorbent for affinity separation, and to make it possible to elute proteases, such as alkaline glothiase, with a neutral to weakly basic aqueous solution.
It is an object of the present invention to provide a safe adsorbent for affinity separation having adsorption/elution characteristics sufficient for large-scale purification, and a method for purifying protease using the adsorbent.
(3)問題点を解決するための手段
本発明によれば、サリチル酸、フタル酸またはこレラの
誘導体で少くとも1つのカルボキシル基が修飾されずに
残存するものをリガンドとするアフィニティー分離用吸
着体が提供される。(3) Means for Solving the Problems According to the present invention, an adsorbent for affinity separation in which the ligand is a derivative of salicylic acid, phthalic acid, or cholera in which at least one carboxyl group remains unmodified. is provided.
本発明のアフィニティー分離用吸着体は、上記リガンド
を直接担体に固定化したもの又は担体上で、該リガンド
となり得る物質を合成したものである。リガンドを直接
担体に固定化する場合、リガンドの分子中にアミン基、
水酸基等の担体と結合反応させやすい官能基(以後、特
にことわりのない限り「官能基」と略す)が少なくとも
一つ以上含まれている必要がある。The adsorbent for affinity separation of the present invention is one in which the above-mentioned ligand is directly immobilized on a carrier, or one in which a substance that can serve as the ligand is synthesized on the carrier. When immobilizing a ligand directly on a carrier, amine groups,
It is necessary to contain at least one functional group (hereinafter abbreviated as "functional group" unless otherwise specified) that is likely to cause a bonding reaction with a carrier, such as a hydroxyl group.
本発明に用いるリガンドの官能基は使用する担体とリガ
ンドとを結合可能なものであればよく、例えば、アミノ
基、カルボキシル基、ホルミル基。The functional group of the ligand used in the present invention may be any functional group as long as it can bind the carrier used and the ligand, such as an amino group, a carboxyl group, and a formyl group.
水酸基等が挙げられるが、これらに限定されるものでは
ない。また、これらリガンドの種類は種々あり、特に゛
限定されるものではないが、例えば、官能基がアミノ基
の場合、5−(4−アミノフェニルアゾ)サリチル酸、
4−・アミンサリチル酸。Examples include, but are not limited to, hydroxyl groups. There are various types of these ligands, and they are not particularly limited. For example, when the functional group is an amino group, 5-(4-aminophenylazo)salicylic acid,
4-Amine salicylic acid.
フタル酸、4−アミノフタル酸、2.3−ジヒドロ安息
香酸、2.4−ジヒドロ安息香酸、オルセリン酸、キノ
リン酸等がある。Examples include phthalic acid, 4-aminophthalic acid, 2,3-dihydrobenzoic acid, 2,4-dihydrobenzoic acid, orceric acid, and quinolinic acid.
本発明のリガンドを担体上で合成する場合、5−(4−
アミノフェニルアゾ)サリチル酸、フタル酸モノアミド
等が合成でき、合成法としては、脱水縮合やジアゾカッ
プリング等の一般的合成法を適応すればよい。When the ligand of the present invention is synthesized on a carrier, 5-(4-
Aminophenylazo)salicylic acid, phthalic acid monoamide, etc. can be synthesized, and general synthesis methods such as dehydration condensation and diazo coupling can be applied.
本発明に用いる担体としては、アガロース、セルロース
、デキストラン、ポリアクリルアミド。Examples of carriers used in the present invention include agarose, cellulose, dextran, and polyacrylamide.
ポリビニルアルコ−・ル、キトサン、多孔性ガラス等の
アフィニティー分離に於て通常用いられる担体はいずれ
も例外なく用いられる。アガロース系担体の具体的商品
としては、例えば、セファデックス(Pharmaci
m社登録商標、以下■と略称する)。All carriers commonly used in affinity separation, such as polyvinyl alcohol, chitosan, and porous glass, can be used without exception. Specific commercial products of agarose-based carriers include, for example, Sephadex (Pharmaci
m company registered trademark, hereinafter abbreviated as ■).
バイオグルA (BIO−RAD社■)等があり、セル
ロース系のものとしては、例えば、セルロファイン(チ
ッソ(株)■)、デキストラン系のものとしては、例え
ば、セファデックス(Pharmacia社■)、ポリ
アクリルアミド系のものとしては、例えば、エンデフィ
ックスP(和光紬薬@)■)、ポリビニルアルコール系
のものとしては、例えば、トヨパール(東洋曹達(株)
■)、セA?ビーズ(三菱化成(株)■)、キトサン系
のものとしては、例えば、キ) ノ4−ル(昭和電工(
株)■)等が各々市販されているが、これらクロマトグ
ラフィー用担体に限定されるものではない。また、これ
ら担体の種類は種々あり、特に限定されるものではない
が、例えば、官能基がアミン基の場合には担体にCNB
r活性化セファロース4 B 、 CH−セファロー
ス4B。Bioglu A (BIO-RAD ■), etc. Cellulose-based products include Cellulofine (Chisso Corporation ■), and dextran-based products include Sephadex (Pharmacia ■) and Polymer. Examples of acrylamide-based products include Endefix P (Wako Tsumugi Pharmaceutical @)■), and examples of polyvinyl alcohol-based products include Toyo Pearl (Toyo Soda Co., Ltd.).
■), SeA? Beads (Mitsubishi Kasei Co., Ltd.), chitosan-based products such as
Co., Ltd. ■) and the like are commercially available, but the carrier for chromatography is not limited to these. In addition, there are various types of these carriers, and they are not particularly limited. For example, when the functional group is an amine group, the carrier has CNB.
r-activated Sepharose 4B, CH-Sepharose 4B.
活性化CH−セファロース4B、エポキシ活性化セファ
ロース4B等も用いることができる。Activated CH-Sepharose 4B, epoxy activated Sepharose 4B, etc. can also be used.
リガンドを担体に固定化する場合、担体の種類、即ち担
体側の活性基及び官能基により異なるが、いずれも一般
的固定化担体の調整法が適応できる。When immobilizing a ligand on a carrier, it depends on the type of carrier, that is, the active group and functional group on the carrier side, but in any case, general methods for preparing immobilized carriers can be applied.
一方、本発明のアフィニティー分離用吸着体で精製可能
な酵素としては、アルカリグロテアーピを中心にして、
スブチリシンBPN’ 、スプチリシンカールスベルグ
、カズサーゼ(昭和電工@)■)。On the other hand, enzymes that can be purified using the adsorbent for affinity separation of the present invention include Alkaline Groteapi,
subtilisin BPN', subtilisin Carlsberg, Kazusase (Showa Denko@)■).
アルカラーゼ(NoVO社■)、サビナーゼ(NoVO
社■)、エスペラーゼ(NoVO社■)、キモトリグシ
ン等があるが、これらに限定されるものではない。Alcalase (NoVO), Savinase (NoVO)
Examples include, but are not limited to, Esperase (NoVO Company ■), Chymotrigsin, and the like.
(4)作用
本発明によって得られたアフィニティー分離用吸着体は
一般的な担体を使用できるため、充填塔方式や流動層方
式をはじめとする移動層方式等によって実用化できる。(4) Function Since the adsorbent for affinity separation obtained by the present invention can use a general carrier, it can be put to practical use in a moving bed system such as a packed column system or a fluidized bed system.
しかも、本発明のリガンドは水系の溶液で吸着溶離がで
きる所にメリットおよび特徴がある。Moreover, the ligand of the present invention has the advantage and feature that it can be adsorbed and eluted with an aqueous solution.
従って、従来のように溶離に有機溶媒を用いて分離精製
する工程や、除害設備の必要なアルソン酸系のリガンド
を用いたものに比較して、はるかにプロセスが単純であ
り、また、フェニルホウ酸系のリガンドを用いたものよ
り溶離しやすく高い回収率を得やすいので、工業的に有
利な方法である。Therefore, the process is much simpler than conventional separation and purification processes using organic solvents for elution, or processes using arsonic acid-based ligands that require detoxification equipment. This is an industrially advantageous method because it is easier to elute and obtain a higher recovery rate than those using acid-based ligands.
(5)実施例
以下に実施例を挙げる。実施例中の酵素の定量は、TN
BS法により行なった。(5) Examples Examples are given below. Enzyme quantification in the examples was performed using TN
This was done using the BS method.
実施例1
5−(4−アミノフェニルアゾ)サリチル酸の固定化活
性化CH−セファロ−y、 4 B (Pharmac
ia社■)3Sに氷冷した1 0 mM HCL水溶液
15−を加え、約15分間攪拌し樹脂を膨潤させ、グラ
スフィルター上に樹脂を移し、氷冷した1 0 mM
HCt水溶液600m1で洗浄した。次いで氷冷した1
00mM炭酸水素ナトリウム水溶液20rnlで手早く
洗浄し、ただちに樹脂を10mM 5− (4−アミノ
フェニルアゾ)サリチル酸を含む100mM炭酸水素ナ
トリウム水溶1(p)18.0)50ゴ中に移し、室温
で一昼夜攪拌した。反応後、樹脂を再びグラスフィルタ
ー上に移し、P液に色がなくなるまで100 mM炭酸
水素す) IJウム水溶液で洗浄し、目的とする吸着体
を得た。この吸着体には、I Q−’mQtS(樹脂)
の5−(4−アミノフェニルアゾ)サリチル酸が固定化
された。Example 1 Immobilization of 5-(4-aminophenylazo)salicylic acid activated CH-cephalo-y, 4B (Pharmac
Add ice-cooled 10 mM HCL aqueous solution 15- to 3S, stir for about 15 minutes to swell the resin, transfer the resin onto a glass filter, and add ice-cooled 10 mM HCL aqueous solution 15- to 3S.
Washed with 600 ml of HCt aqueous solution. Then ice-cooled 1
Wash quickly with 20ml of 00mM sodium bicarbonate aqueous solution, and immediately transfer the resin to 100mM sodium hydrogencarbonate aqueous solution 1(p)18.0) containing 10mM 5-(4-aminophenylazo)salicylic acid (p), and stir overnight at room temperature. did. After the reaction, the resin was transferred onto a glass filter again and washed with an aqueous solution of 100 mM hydrogen carbonate until the P solution lost its color, to obtain the desired adsorbent. This adsorbent contains IQ-'mQtS (resin)
5-(4-aminophenylazo)salicylic acid was immobilized.
実施例2
5−(4−アミノフェニルアゾ)サリチル酸の担体上で
の合成
モノやビーズCM−13100gをジオキサ7500m
1で3回洗浄し、樹脂をジオキサン300 ml中に移
した。これに、ジシクロへキシルカルどジイミド5Iと
p−フェニレンジアミン10gとを加え、室温で一昼夜
攪拌した。次に、樹脂をジオキサンsoomz及び水5
QQmJで3回ずつ洗浄し、樹脂を氷冷した1M塩酸5
00d中に少しずつ加え、液温を4℃に保ちながら、亜
硝酸ナトリウム29を少しずつ加え、約3時間反応させ
た。反応後、樹脂を氷冷水5QQm/で洗浄し、樹脂を
水300m1中に移し液温10℃以下、pH8〜9に保
ちながら、サリチル酸5gを加え、約3時間反応させた
。Example 2 Synthesis of 5-(4-aminophenylazo)salicylic acid on a carrier and beads CM-13 (100 g) were mixed with 7,500 m of dioxa
1 and the resin was transferred into 300 ml of dioxane. To this were added dicyclohexylcaldodiimide 5I and 10 g of p-phenylenediamine, and the mixture was stirred at room temperature all day and night. The resin was then treated with dioxane soomz and water 5
The resin was washed three times with QQmJ, and the resin was washed with ice-cooled 1M hydrochloric acid 5.
Sodium nitrite 29 was added little by little while keeping the liquid temperature at 4°C, and the mixture was reacted for about 3 hours. After the reaction, the resin was washed with 5 QQm of ice-cold water, and the resin was transferred to 300 ml of water, and while maintaining the liquid temperature at 10 DEG C. or less and the pH at 8 to 9, 5 g of salicylic acid was added, and the mixture was allowed to react for about 3 hours.
反応後10mM水酸化ナトリウム溶液、10mM塩酸。After reaction, add 10mM sodium hydroxide solution and 10mM hydrochloric acid.
水で各500dずつで順次洗浄し、目的とする吸着体を
得た。この吸着体には、10−4〜10−5mot/m
l (樹脂)の5−(4−アミノフェニルアゾ)サリチ
ル酸が固定化された。The target adsorbent was obtained by sequentially washing with water for 500 d each. This adsorbent has 10-4 to 10-5 mot/m
1 (resin) of 5-(4-aminophenylazo)salicylic acid was immobilized.
実施例3
フタル酸モノアミドの担体上での合成
セパビーズ臥−13100Nをジオキサン500m1で
3回洗浄し、無水フタル酸10%ジオキサン溶液30O
rnl中に樹脂を移し、室温で一昼夜攪拌した。次に、
樹脂f、3回ず・つ、ジオキサン500m1次いで水5
00 mlで洗浄し、目的とする吸着体を得た。この吸
着体には、10−’ 〜10−’ mol/ml(樹脂
)のフタル酸モノアミドが固定化された。Example 3 Synthesis of phthalic acid monoamide on a carrier Sepa beads 襥-13100N were washed three times with 500 ml of dioxane, and a 10% dioxane solution of phthalic anhydride 300
The resin was transferred into rnl and stirred at room temperature overnight. next,
Resin f, 3 times, 500 ml of dioxane, then 500 ml of water
00 ml to obtain the target adsorbent. Phthalic acid monoamide of 10-' to 10-' mol/ml (resin) was immobilized on this adsorbent.
実施例4
アフィニティークロマトグラフィー法による精製1)吸
着分離
実施例1〜3の吸着体それぞれKついてアフィニティー
クロマトグラフィーを行なった。Example 4 Purification by Affinity Chromatography 1) Adsorption Separation Affinity chromatography was performed on each of the adsorbents K of Examples 1 to 3.
1.2cWIφ×40傭のカラムに樹脂を充填し、2〇
−燐酸緩衝液(pH9)であらかじめカラムを平衡化し
ておき、アフィニティークロマトグラフィーを開始した
。pH9Fc調製した1チカズサーゼ(昭和電工(株)
)酵素原木水溶液1000111/ ’i粗試料として
カラムに添加し、酵素を樹脂に吸着させた。A column of 1.2 cWIφ×40 liters was filled with the resin, the column was equilibrated in advance with 20-phosphate buffer (pH 9), and affinity chromatography was started. 1 Chikazusase prepared with pH9Fc (Showa Denko K.K.)
) Enzyme log aqueous solution 1000111/'i was added to the column as a crude sample to adsorb the enzyme onto the resin.
次に20 mM燐酸緩衝液(pH9) 500mlテカ
ラAを洗浄し、200mM硫酸ナトリウムを含む20m
M燐酸緩衝液(pH6)50omJ(実施例3のみ10
00m/)で酵素を溶出させた。結果を表IK示した0
2)分離条件
実施例2の吸着体について、粗試料の−及び溶出液の声
、塩濃度、塩の種類を変えて実施例4−1)と同様にア
フィニティークロマトグラフィーを行なった。なお、カ
ラムの平衡化の−及び洗浄の声は粗試料の−と同じにし
た。結果を表2,3に示した0
3)拳法によって精製された酵素の比活性は300 n
k/A28o以上であり、著しく高純度の酵素が得られ
た。本酵素溶液は無色透明であり、この凍結乾燥粉末は
白色であり、酵素造粒品に使用すれば、化粧剤を使用し
なくても充分使用に耐えるきれいなものができる。Next, wash 500ml Tekara A with 20mM phosphate buffer (pH 9) and add 20mM phosphate buffer (pH 9) containing 20mM sodium sulfate.
M phosphate buffer (pH 6) 50 omJ (Example 3 only 10
The enzyme was eluted at 00 m/). The results are shown in Table IK.0 2) Separation conditions The adsorbent of Example 2 was subjected to affinity chromatography in the same manner as in Example 4-1) by changing the volume, salt concentration, and type of salt of the crude sample and eluate. I did it. Note that the column equilibration and washing instructions were the same as those for the crude sample. The results are shown in Tables 2 and 3. 3) The specific activity of the enzyme purified by Kempo is 300 n.
k/A was 28o or more, and an enzyme of extremely high purity was obtained. The present enzyme solution is colorless and transparent, and the freeze-dried powder is white, and when used in enzyme granules, a product that is clean enough to withstand use without the use of cosmetics can be produced.
実施例6
酵素をアルカラーゼ(NoVO社)として同様に実施例
1のカラムを用いて分離した結果、pH9において吸着
し、PH6,硫酸ナトリウム200mMの溶離液で溶離
し、酵素吸着量40In9/ff1A’(樹脂)回収率
99%で回収し、乾燥することによって白色の酵素原末
を得た。Example 6 The enzyme was separated using the column of Example 1 using Alcalase (NoVO). As a result, it was adsorbed at pH 9, eluted with an eluent of pH 6 and sodium sulfate 200 mM, and the enzyme adsorption amount was 40 In9/ff1A' ( Resin) was collected at a recovery rate of 99% and dried to obtain a white enzyme bulk powder.
実施例7
酵素をスプチリシンBPN’(SIGMA社)として同
様に実施例1のカラムを用いて分離した結果、−9にお
いて吸着し、PH6,硫酸ナトリウム200mMの溶離
液で溶離し、酵素吸着量42In9/m(樹脂)1回収
率98チで回収し、乾燥することによって白色の酵素原
末を得た。Example 7 Enzyme was separated using the column of Example 1 using Sptilisin BPN' (SIGMA). As a result, it was adsorbed at -9, eluted with an eluent of pH 6 and sodium sulfate 200mM, and the enzyme adsorption amount was 42In9/ The resin was collected at a recovery rate of 98 cm (resin) and dried to obtain a white enzyme bulk powder.
実施例8
酵素をα−キモトリプシン(SIGMA 社) トして
同様に実施例1のカラムを用いて分離した結果、p)1
8におイテ吸着し、PH6,硫酸ナトリウムZo。Example 8 As a result of separating the enzyme using α-chymotrypsin (SIGMA) in the same manner using the column of Example 1, p)1
8, pH 6, sodium sulfate Zo.
−の溶離液で溶離し、酵素吸着量241n97ml (
樹脂)9回収率88%で回収した。- Elute with an eluent of -, enzyme adsorption amount 241n97ml (
Resin) 9 was recovered with a recovery rate of 88%.
表1 各アフィニティー分離剤による酵素の分離結果実
施例1 28 101 7
8実施例3 33 98
72実施例4 51 90
69注1)0回収率=溶出酵素i/吸着酵量注2
)、精製率=溶出酵素の比活性/粗試料比活性(粗試料
の比活性= 4.4 nkat/A280 )表2 吸
着条件の影響
粗試料の−酵素吸着量(m9蛋白質/at樹脂)表3
溶出条件の影響
溶出液の−添 加 塩 添加塩濃度(mM) 溶出
率(%)9 塩化ナトリウム 100
986 # tt
739 硫酸ナトリウム
50 666 1/
100 959 #
500 91注1)、添加塩とは、20
mM燐酸緩衝剤の他に添加した塩を指す。Table 1 Enzyme separation results using each affinity separation agent Example 1 28 101 7
8 Example 3 33 98
72 Example 4 51 90
69 Note 1) 0 recovery rate = eluted enzyme i/adsorbed fermentation amount Note 2
), Purification rate = specific activity of eluted enzyme / specific activity of crude sample (specific activity of crude sample = 4.4 nkat/A280) Table 2 Effect of adsorption conditions - Enzyme adsorption amount of crude sample (m9 protein/AT resin) Table 3
Effect of elution conditions Added salt to eluate Added salt concentration (mM) Elution rate (%) 9 Sodium chloride 100
986 #tt
739 Sodium sulfate
50 666 1/
100 959 #
500 91 Note 1), added salt is 20
Refers to salts added in addition to mM phosphate buffer.
注2)、溶出率=溶出酵素量/吸着酵素量(7)発明の
効果
本発明の吸着体は、吸着体1 ml当り酵素蛋白質を2
0〜30■以上吸着することができ、従来のアフィニテ
ィー吸着体の2〜数十倍の吸着能を持つ。従来、酵素の
大量精製に於て、アフィニティ−分離法は十分効率の良
い方法ではなく実用化はされていなかったが、本発明の
吸着体を用いれば、洗剤用酵素等の大量精製を必要とす
るものに対しても十分にアフィニティー分離法を活用で
きる。Note 2), Elution rate = Amount of eluted enzyme / Amount of adsorbed enzyme (7) Effects of the invention The adsorbent of the present invention has a concentration of 2 enzyme proteins per 1 ml of the adsorbent.
It can adsorb 0 to 30 cm or more, and has an adsorption capacity of 2 to several tens of times that of conventional affinity adsorbents. Conventionally, the affinity separation method was not a sufficiently efficient method for large-scale purification of enzymes and had not been put to practical use. However, if the adsorbent of the present invention is used, large-scale purification of enzymes for detergents, etc. is no longer necessary. Affinity separation methods can be fully utilized even for substances that
本発明の吸着体は、少なくともpH6〜10、好ましく
はpH6〜9において酵素を吸着し、少なくともpH6
〜9の溶出液に塩1100mM以上添加することにより
溶出可能である。The adsorbent of the present invention adsorbs enzymes at a pH of at least 6 to 10, preferably at a pH of 6 to 9, and at least at a pH of 6 to 9.
Elution is possible by adding 1100mM or more of salt to the eluate of ~9.
このように、本発明の吸着体を用いたアフィニティー分
離法は、大量精製に於て十分な吸着容量で、有機溶媒等
を使わずに塩類の水溶液のみで、粗酵素液等からアルカ
リグロチアーゼを選択的に分離精製できることを大きな
特徴とする。As described above, the affinity separation method using the adsorbent of the present invention has sufficient adsorption capacity for large-scale purification, and it is possible to separate alkaline glothiase from crude enzyme solution etc. using only an aqueous salt solution without using an organic solvent or the like. A major feature is that it can selectively separate and purify.
水沫によって得られた酵素はかなり比活性が高く、また
、不純物(例えば色成分)の少ないものが得られるので
各種用途の酵素、特に液体洗剤用酵素等として極めて有
用である。The enzyme obtained by water droplet has a considerably high specific activity and contains few impurities (for example, color components), so it is extremely useful as an enzyme for various uses, especially as an enzyme for liquid detergents.
特許出願人 昭和電工株式会社Patent applicant: Showa Denko Co., Ltd.
Claims (1)
も1つのカルボキシル基が修飾されないで残存するもの
をリガンドとするプロテアーゼのアフィニティー分離用
吸着体。An adsorbent for affinity separation of protease, which uses salicylic acid, phthalic acid, or a derivative thereof in which at least one carboxyl group remains unmodified as a ligand.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63003567A JPH01180451A (en) | 1988-01-11 | 1988-01-11 | Adsorptive body for affinity separation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63003567A JPH01180451A (en) | 1988-01-11 | 1988-01-11 | Adsorptive body for affinity separation |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH01180451A true JPH01180451A (en) | 1989-07-18 |
Family
ID=11561012
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP63003567A Pending JPH01180451A (en) | 1988-01-11 | 1988-01-11 | Adsorptive body for affinity separation |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH01180451A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1069131A1 (en) * | 1999-07-15 | 2001-01-17 | QIAGEN GmbH | Methods for separating particulate substrates from solution while minimizing particle loss |
CN102274715A (en) * | 2011-05-23 | 2011-12-14 | 南京工业大学 | Modified metal organic framework porous adsorption material and working substance pair adsorbed by same |
-
1988
- 1988-01-11 JP JP63003567A patent/JPH01180451A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1069131A1 (en) * | 1999-07-15 | 2001-01-17 | QIAGEN GmbH | Methods for separating particulate substrates from solution while minimizing particle loss |
CN102274715A (en) * | 2011-05-23 | 2011-12-14 | 南京工业大学 | Modified metal organic framework porous adsorption material and working substance pair adsorbed by same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU683588B2 (en) | Chromatographic resins and methods for using same | |
Gaberc‐Porekar et al. | Potential for using histidine tags in purification of proteins at large scale | |
JP4559216B2 (en) | Method, use and kit for separating albumin from contaminants in liquid | |
JP3768485B2 (en) | Purification method of serum albumin | |
KR20100070994A (en) | Packing material for liquid chromatography and process for separation and purification of biopolymer by means of the packing material | |
WO2009008802A1 (en) | Method for preparation of a biomolecule adsorbent | |
US5849874A (en) | Process for the purification of serum albumin | |
Roy et al. | Current trends in affinity-based separations of proteins/enzymes | |
JPS5832591B2 (en) | Purification method of urokinase | |
EP0245222B1 (en) | Nitrilophoric electron-donor-acceptor-adsorbents | |
EP2301950A1 (en) | Separating agent for purification of protein, and protein purification method | |
EP0085661B1 (en) | Metal ion adsorbent | |
JPH01180451A (en) | Adsorptive body for affinity separation | |
Clonis et al. | Monosized adsorbents for high-performance affinity chromatography: application to the purification of calf intestinal alkaline phosphatase and human urine urokinase | |
US5290685A (en) | Method for separation and concentration of phosphopeptides | |
Ke et al. | Preparation of the immobilized metal affinity membrane with high amount of metal ions and protein adsorption efficiencies | |
US5688912A (en) | Peptide ligands which bind to von willebrand factor | |
Kanamori et al. | Preparation of high-capacity affinity adsorbents using formyl carriers and their use for low-and high-performance liquid affinity chromatography of trypsin-family proteases | |
SU644796A1 (en) | Method of purifying proteolytic ferments | |
JPH0466559B2 (en) | ||
JPH06197757A (en) | Method for separating beta-amylase | |
JPH0147997B2 (en) | ||
Taniguchi et al. | Purification of staphylococcal Protein A by affinity precipitation: dissociation of Protein A from the adsorbent with chemical reagents | |
SU551339A1 (en) | The method of purification of enzyme preparations | |
SU942427A1 (en) | Method for purifying proteolytic enzymes |